Figure 5
Figure 5. Cerebrovascular CO2 responsiveness (CCR) in SCD patients with and without hydroxyurea. (A) Cerebrovascular CO2 responsiveness expressed as relative change in mean CBF velocity (percentage ΔVmean) per millimeter of mercury change in PETCO2 (CCR-TCD) was higher in SCD patients using hydroxyurea (Hydroxy+, , n = 10) than in those not using hydroxyurea (Hydroxy−, ■, n = 13), although the difference was not statistically significant. (B) Cerebrovascular CO2 responsiveness expressed as absolute changes (Δ μmol/L) in cerebral [O2Hb], [dHb], and [t-Hb] per millimeter of mercury PETCO2 were also higher in SCD patients using hydroxyurea (n = 7) than in those not using hydroxyurea (n = 7), although the difference was only statistically significant for dHb-derived cerebrovascular CO2 responsiveness. Data are mean ± SEM.

Cerebrovascular CO2 responsiveness (CCR) in SCD patients with and without hydroxyurea. (A) Cerebrovascular CO2 responsiveness expressed as relative change in mean CBF velocity (percentage ΔVmean) per millimeter of mercury change in PETCO2 (CCR-TCD) was higher in SCD patients using hydroxyurea (Hydroxy+, , n = 10) than in those not using hydroxyurea (Hydroxy, ■, n = 13), although the difference was not statistically significant. (B) Cerebrovascular CO2 responsiveness expressed as absolute changes (Δ μmol/L) in cerebral [O2Hb], [dHb], and [t-Hb] per millimeter of mercury PETCO2 were also higher in SCD patients using hydroxyurea (n = 7) than in those not using hydroxyurea (n = 7), although the difference was only statistically significant for dHb-derived cerebrovascular CO2 responsiveness. Data are mean ± SEM.

Close Modal

or Create an Account

Close Modal
Close Modal